Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.860
+0.120 (6.90%)
At close: Nov 20, 2024, 4:00 PM
1.861
+0.001 (0.06%)
After-hours: Nov 20, 2024, 6:05 PM EST
Milestone Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | 1 | 5 | 15 | - | - | |
| Revenue Growth (YoY) | - | -80.00% | -66.67% | - | - | - | |
| Gross Profit | - | 1 | 5 | 15 | - | - | |
| Selling, General & Admin | 27.69 | 31.05 | 24.81 | 19.4 | 16.22 | 15.9 | |
| Research & Development | 15.87 | 31.05 | 39.83 | 38.67 | 34.49 | 41.99 | |
| Operating Expenses | 43.55 | 62.1 | 64.64 | 58.07 | 50.71 | 57.88 | |
| Operating Income | -43.55 | -61.1 | -59.64 | -43.07 | -50.71 | -57.88 | |
| Interest Expense | -3.52 | -2.55 | - | - | - | - | |
| Interest & Investment Income | 4.31 | 3.97 | 1.25 | 0.22 | 0.73 | 2.6 | |
| Pretax Income | -42.77 | -59.69 | -58.39 | -42.85 | -49.98 | -55.29 | |
| Income Tax Expense | - | - | - | - | -0.02 | -0.06 | |
| Net Income | -42.77 | -59.69 | -58.39 | -42.85 | -49.97 | -55.23 | |
| Net Income to Common | -42.77 | -59.69 | -58.39 | -42.85 | -49.97 | -55.23 | |
| Shares Outstanding (Basic) | 56 | 43 | 42 | 42 | 29 | 16 | |
| Shares Outstanding (Diluted) | 56 | 43 | 42 | 42 | 29 | 16 | |
| Shares Change (YoY) | 31.53% | 1.19% | 1.47% | 42.56% | 85.91% | 4845.07% | |
| EPS (Basic) | -0.76 | -1.39 | -1.38 | -1.02 | -1.70 | -3.50 | |
| EPS (Diluted) | -0.76 | -1.39 | -1.38 | -1.02 | -1.70 | -3.50 | |
| Free Cash Flow | - | -46.54 | -52.74 | -33.22 | -50.73 | -51.57 | |
| Free Cash Flow Per Share | - | -1.08 | -1.24 | -0.79 | -1.73 | -3.27 | |
| Gross Margin | - | 100.00% | 100.00% | 100.00% | - | - | |
| Operating Margin | - | -6109.80% | -1192.84% | -287.15% | - | - | |
| Profit Margin | - | -5968.50% | -1167.76% | -285.69% | - | - | |
| Free Cash Flow Margin | - | -4653.60% | -1054.82% | -221.49% | - | - | |
| EBITDA | -43.45 | -61.01 | -59.55 | -42.98 | -50.61 | -57.84 | |
| EBITDA Margin | - | - | - | -286.53% | - | - | |
| D&A For EBITDA | 0.1 | 0.09 | 0.09 | 0.09 | 0.1 | 0.04 | |
| EBIT | -43.55 | -61.1 | -59.64 | -43.07 | -50.71 | -57.88 | |
| EBIT Margin | - | - | - | -287.15% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.